Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
21 June 2018Website:
http://www.kezarlifesciences.comNext earnings report:
09 August 2024Last dividends:
N/ANext dividends:
N/APrice
pre-market | 18 min agoDividend
Analysts recommendations
Institutional Ownership
KZR Latest News
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer, today announced that the Compensation Committee of the company's Board of Directors granted one employee a nonqualified stock option to purchase 80,000 shares of its common stock with an exercise price of $0.71 per share, which is equal to the closing price of Kezar'.
Kezar (KZR) falls 10% on the decision to channel resources to one clinical candidate as part of its reprioritization efforts and slash the workforce by 41%.
What type of business is Kezar Life Sciences?
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b clinical trials in systemic lupus erythematosus and lupus nephritis. Its preclinical products include KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of KZR-261; and KZR-TBD for the treatment of oncology and immunology. The company was incorporated in 2015 and is based in South San Francisco, California.
What sector is Kezar Life Sciences in?
Kezar Life Sciences is in the Healthcare sector
What industry is Kezar Life Sciences in?
Kezar Life Sciences is in the Biotechnology industry
What country is Kezar Life Sciences from?
Kezar Life Sciences is headquartered in United States
When did Kezar Life Sciences go public?
Kezar Life Sciences initial public offering (IPO) was on 21 June 2018
What is Kezar Life Sciences website?
https://www.kezarlifesciences.com
Is Kezar Life Sciences in the S&P 500?
No, Kezar Life Sciences is not included in the S&P 500 index
Is Kezar Life Sciences in the NASDAQ 100?
No, Kezar Life Sciences is not included in the NASDAQ 100 index
Is Kezar Life Sciences in the Dow Jones?
No, Kezar Life Sciences is not included in the Dow Jones index
When does Kezar Life Sciences report earnings?
The next expected earnings date for Kezar Life Sciences is 09 August 2024